iShares US Pharmaceuticals ETF
IHE
IHE
87 hedge funds and large institutions have $197M invested in iShares US Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
49% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 39
Holders
87
Holding in Top 10
3
Calls
$259K
Puts
–
Top Buyers
| 1 | +$10.4M | |
| 2 | +$2.79M | |
| 3 | +$2M | |
| 4 |
MFS
MSI Financial Services
Springfield,
Massachusetts
|
+$737K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$606K |
Top Sellers
| 1 | -$6.99M | |
| 2 | -$4.97M | |
| 3 | -$4.07M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.55M |
| 5 |
SFI
SPC Financial Inc
Rockville,
Maryland
|
-$2.37M |